We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
febit Launches Whole Genome Sequencing Service in Europe
News

febit Launches Whole Genome Sequencing Service in Europe

febit Launches Whole Genome Sequencing Service in Europe
News

febit Launches Whole Genome Sequencing Service in Europe

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "febit Launches Whole Genome Sequencing Service in Europe"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

febit has announced that the company now offers whole genome sequencing services in Europe for a broad range of species. febit is known for its targeted resequencing services and instruments for genome exploration.

febit has acquired two Applied Biosystems SOLiD™ high-throughput sequencing systems from Life Technologies Corporation, necessary for whole genome resequencing. One of the two systems will be used within R&D while the other is employed within febit’s Genomic Service Department. Life Technologies is a global biotechnology tools company providing premier systems, consumables, and services for scientific researchers around the world.

“We combine our expertise in optimizing samples for highest coverage in targeted resequencing with the established SOLiD sequencing power,” said Peer Staehler, CSO of febit. “This will enable us to offer whole genome sequencing at very competitive prices; the price for resequencing a whole human genome will start at 9,750 Euro.  The ultra-deep resequencing with 99.94 % accuracy allows confident SNP and mutation detection as well as the detection of structural variations such as insertions, deletions, inversions and translocations.”

The new whole genome resequencing service extends febit’s service portfolio which is already well established for targeted resequencing of genomic regions of interest with its high throughput HybSelect-technology. Together with a barcoding option, febit’s new service portfolio will advance the use of next-generation sequencing for larger scale clinical studies due to effective costs and data management.
Advertisement